In a study by Deng et al. [55], which focused on immunotherapy in NPC, it was found that higher PDL-1 expression levels correlated with lower CD163 expression, and both were associated with more favorable survival outcomes. Here, CD163 is linked to nasopharyngeal carcinoma.